Zhou HH - Search Results

1

Pharmacokinetics of citalopram in relation to genetic polymorphism of CYP2C19.

Yu BN, Chen GL, He N, Ouyang DS, Chen XP, Liu ZQ, Zhou HH. Yu BN, et al. Among authors: zhou hh. Drug Metab Dispos. 2003 Oct;31(10):1255-9. doi: 10.1124/dmd.31.10.1255. Drug Metab Dispos. 2003. PMID: 12975335

2

High-performance liquid chromatographic determination of urinary 4'-hydroxymephenytoin, a metabolic marker for the hepatic enzyme CYP2C19, in humans.

Xie HG, Huang SL, Zhou HH. Xie HG, et al. Among authors: zhou hh. J Chromatogr B Biomed Appl. 1995 Jun 9;668(1):125-31. doi: 10.1016/0378-4347(95)00065-q. J Chromatogr B Biomed Appl. 1995. PMID: 7550968

3

The elimination of diazepam in Chinese subjects is dependent on the mephenytoin oxidation phenotype.

Wan J, Xia H, He N, Lu YQ, Zhou HH. Wan J, et al. Among authors: zhou hh. Br J Clin Pharmacol. 1996 Oct;42(4):471-4. doi: 10.1046/j.1365-2125.1996.42712.x. Br J Clin Pharmacol. 1996. PMID: 8904619 Free PMC article.

4

In vivo inhibition of CYP2C19 but not CYP2D6 by fluvoxamine.

Xu ZH, Xie HG, Zhou HH. Xu ZH, et al. Among authors: zhou hh. Br J Clin Pharmacol. 1996 Oct;42(4):518-21. doi: 10.1046/j.1365-2125.1996.45319.x. Br J Clin Pharmacol. 1996. PMID: 8904628 Free PMC article.

5

Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele.

Xiao ZS, Goldstein JA, Xie HG, Blaisdell J, Wang W, Jiang CH, Yan FX, He N, Huang SL, Xu ZH, Zhou HH. Xiao ZS, et al. Among authors: zhou hh. J Pharmacol Exp Ther. 1997 Apr;281(1):604-9. J Pharmacol Exp Ther. 1997. PMID: 9103550

6

Evidence for the effect of gender on activity of (S)-mephenytoin 4'-hydroxylase (CYP2C19) in a Chinese population.

Xie HG, Huang SL, Xu ZH, Xiao ZS, He N, Zhou HH. Xie HG, et al. Among authors: zhou hh. Pharmacogenetics. 1997 Apr;7(2):115-9. doi: 10.1097/00008571-199704000-00004. Pharmacogenetics. 1997. PMID: 9170148

7

Effect of troleandomycin on the pharmacokinetics of imipramine in Chinese: the role of CYP3A.

Wang JS, Wang W, Xie HG, Huang SL, Zhou HH. Wang JS, et al. Among authors: zhou hh. Br J Clin Pharmacol. 1997 Aug;44(2):195-8. doi: 10.1046/j.1365-2125.1997.00649.x. Br J Clin Pharmacol. 1997. PMID: 9278210 Free PMC article. Clinical Trial.

8

Meta-analysis of phenotype and genotype of NAT2 deficiency in Chinese populations.

Xie HG, Xu ZH, Ou-Yang DS, Shu Y, Yang DL, Wang JS, Yan XD, Huang SL, Wang W, Zhou HH. Xie HG, et al. Among authors: zhou hh. Pharmacogenetics. 1997 Dec;7(6):503-14. doi: 10.1097/00008571-199712000-00009. Pharmacogenetics. 1997. PMID: 9429236

9

The induction effect of rifampicin on activity of mephenytoin 4'-hydroxylase related to M1 mutation of CYP2C19 and gene dose.

Feng HJ, Huang SL, Wang W, Zhou HH. Feng HJ, et al. Among authors: zhou hh. Br J Clin Pharmacol. 1998 Jan;45(1):27-9. doi: 10.1046/j.1365-2125.1998.00643.x. Br J Clin Pharmacol. 1998. PMID: 9489590 Free PMC article.

10

No correlation between side-chain of propranolol oxidation and S-mephenytoin 4'-hydroxylase activity.

Xie HG, Xu ZH, Huang SL, Liu JH, Wu JX, Jiang CH, Zhou HH. Xie HG, et al. Among authors: zhou hh. Zhongguo Yao Li Xue Bao. 1997 May;18(3):216-8. Zhongguo Yao Li Xue Bao. 1997. PMID: 10072936 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

722 results

Search Page

Filters